Qiagen NV Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
6.3%projected annual EPS growth
Analyst Coverage
14analysts covering
FY Revenue (est.)
$2.1Bnext fiscal year
FY EPS (est.)
$2.43next fiscal year
Monitoring Framework
Key Performance Indicators
Net Sales Growth at Constant Exchange Rates (CER) Quarterly-100.0%Target: 1% to 2% CER growth for FY 2026
Adjusted Diluted EPS (CER) Quarterly0.5Target: At least $2.43 CER for FY 2026
Growth Pillars Combined Sales Annually1.5BTarget: At least $2.0 billion by 2028
Research as of 19 Jun 2026